Steris

STE · New York Stock Exchange · Health Care

☆ Follow

Shareholder advocacy aimed at Steris

Nothing recorded yet. That means no campaign in our database names this company, not that none exists.

What shareholders voted on

From Steris’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.

2026

Item	Kind	Support	Outcome
Approved the proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 11, 2026, by the following votes	Say on pay	90.1%	Passed
Renewal of the Board’s authority to issue authorized but unissued shares under Irish law, by the following votes	Company proposal	99.2%	Passed
Approve the renewal of the Board’s authority to opt-out of statutory pre-emption rights under Irish law regarding the issuance of shares for cash, by the following votes	Company proposal	96.1%	Passed
Authorize the Board of the Company or the Audit Committee of the Board to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law by the following votes	Auditor	98.2%	Passed
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2027 by the following votes	Auditor	92.3%	Passed
Appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting by the following votes	Auditor	92.1%	Passed
Election of Louis A. Shapiro	Director	99.3%	Passed
Election of Daniel A. Carestio	Director	99.3%	Passed
Election of Pierre Boulud	Director	99.2%	Passed
Election of Dr. Nirav R. Shah	Director	98.4%	Passed
Election of Paul E. Martin	Director	98.3%	Passed
Election of Dr. Esther M. Alegria	Director	97.1%	Passed
Election of Christopher S. Holland	Director	91.7%	Passed
Election of Dr. Mohsen M. Sohi	Director	91.6%	Passed
Election of Cynthia L. Feldmann	Director	87.1%	Passed

2025

Item	Kind	Support	Outcome
Approved the proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 12, 2025, by the following votes	Say on pay	90.1%	Passed
Renewal of the Board’s authority to issue authorized but unissued shares under Irish law, by the following votes	Company proposal	98.3%	Passed
Approve the renewal of the Board’s authority to opt-out of statutory pre-emption rights under Irish law regarding the issuance of shares for cash, by the following votes	Company proposal	94.1%	Passed
Authorize the Board of the Company or the Audit Committee of the Board to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law by the following votes	Auditor	99.1%	Passed
Appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting by the following votes	Auditor	90.4%	Passed
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2026 by the following votes	Auditor	90.2%	Passed
Election of Louis A. Shapiro	Director	99.5%	Passed
Election of Christopher S. Holland	Director	99.3%	Passed
Election of Daniel A. Carestio	Director	99.3%	Passed
Election of Paul E. Martin	Director	98.6%	Passed
Election of Esther M. Alegria	Director	98.5%	Passed
Election of Dr. Nirav R. Shah	Director	97.5%	Passed
Election of Richard C. Breeden	Director	95.2%	Passed
Election of Cynthia L. Feldmann	Director	93.1%	Passed
Election of Dr. Mohsen M. Sohi	Director	89.9%	Passed

2024

Item	Kind	Support	Outcome
Approved the proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 12, 2024, by the following votes	Say on pay	92.7%	Passed
Renewal of the Board’s authority to issue authorized but unissued shares under Irish law, by the following votes	Company proposal	98.6%	Passed
Approve the renewal of the Board’s authority to opt-out of statutory pre-emption rights under Irish law regarding the issuance of shares for cash, by the following votes	Company proposal	91.7%	Passed
Authorize the Board of the Company or the Audit Committee of the Board to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law by the following votes	Auditor	98.4%	Passed
Appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting by the following votes	Auditor	89.9%	Passed
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2025 by the following votes	Auditor	89.8%	Passed
Election of Dr. Richard M. Steeves	Director	99.2%	Passed
Election of Dr. Nirav R. Shah	Director	98.7%	Passed
Election of Paul E. Martin	Director	98.7%	Passed
Election of Christopher S. Holland	Director	98.7%	Passed
Election of Dr. Esther M. Alegria	Director	98.5%	Passed
Election of Daniel A. Carestio	Director	98.3%	Passed
Election of Richard C. Breeden	Director	94.9%	Passed
Election of Dr. Jacqueline B. Kosecoff	Director	94.8%	Passed
Election of Cynthia L. Feldmann	Director	92.3%	Passed
Election of Dr. Mohsen M. Sohi	Director	92%	Passed

2023

Item	Kind	Support	Outcome
Approved the proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 7, 2023, by the following votes	Say on pay	92.2%	Passed
Renewal of the Board’s authority to issue authorized but unissued shares under Irish law, by the following votes	Company proposal	98.1%	Passed
Approve the renewal of the Board’s authority to opt-out of statutory pre-emption rights under Irish law regarding the issuance of shares for cash, by the following votes	Company proposal	93.5%	Passed
Authorize the Board of the Company or the Audit Committee of the Board to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law by the following votes	Auditor	98.7%	Passed
Appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting by the following votes	Auditor	90.6%	Passed
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2024 by the following votes	Auditor	90.6%	Passed
Election of Esther M. Alegria	Director	99.8%	Passed
Election of Dr. Nirav R. Shah	Director	98.9%	Passed
Election of Christopher S. Holland	Director	98.9%	Passed
Election of Dr. Richard M. Steeves	Director	98.8%	Passed
Election of Daniel A. Carestio	Director	98.5%	Passed
Election of Paul E. Martin	Director	98%	Passed
Election of Dr. Mohsen M. Sohi	Director	95.1%	Passed
Election of Richard C. Breeden	Director	94.7%	Passed
Election of Cynthia L. Feldmann	Director	93%	Passed
Election of Dr. Jacqueline B. Kosecoff	Director	90.2%	Passed

2022

Item	Kind	Support	Outcome
The results of a proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 14, 2022, were as follows	Say on pay	95.7%	Passed
The results of a proposal to authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law were as follows	Auditor	98.3%	Passed
The results of a proposal to appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting were as follows	Auditor	91.5%	Passed
The results of a proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2023 were as follows	Auditor	91.3%	Passed
Election of Christopher S. Holland	Director	99%	Passed
Election of Dr. Nirav R. Shah	Director	98.9%	Passed
Election of Dr. Richard M. Steeves	Director	98.7%	Passed
Election of Daniel A. Carestio	Director	98.5%	Passed
Election of Paul E. Martin	Director	97.5%	Passed
Election of Dr. Mohsen M. Sohi	Director	94.8%	Passed
Election of Richard C. Breeden	Director	93.8%	Passed
Election of Cynthia L. Feldmann	Director	93.7%	Passed
Election of Dr. Jacqueline B. Kosecoff	Director	57.7%	Passed

2021

Item	Kind	Support	Outcome
The results of a proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 14, 2021, were as follows	Say on pay	96.6%	Passed
The results of a proposal to authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law were as follows	Auditor	97.7%	Passed
The results of a proposal to appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting were as follows	Auditor	94.5%	Passed
The results of a proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2022 were as follows	Auditor	94.5%	Passed
Election of Dr. Nirav R. Shah	Director	99.8%	Passed
Election of Christopher S. Holland	Director	99.7%	Passed
Election of Paul E. Martin	Director	99.6%	Passed
Election of Daniel A. Carestio	Director	99.2%	Passed
Election of Dr. Richard M. Steeves	Director	99.1%	Passed
Election of Dr. Mohsen M. Sohi	Director	95.8%	Passed
Election of Cynthia L. Feldmann	Director	95.7%	Passed
Election of Richard C. Breeden	Director	93.6%	Passed
Election of Dr. Jacqueline B. Kosecoff	Director	79.7%	Passed

2020

Item	Kind	Support	Outcome
The results of a proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 12, 2020, were as follows	Say on pay	96.3%	Passed
The results of a proposal to authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law were as follows	Auditor	99.8%	Passed
The results of a proposal to appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting were as follows	Auditor	96.1%	Passed
The results of a proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2021 were as follows	Auditor	95.7%	Passed
Election of Dr. Nirav R. Shah	Director	99.8%	Passed
Election of Walter M Rosebrough, Jr.	Director	98.9%	Passed
Election of David B. Lewis	Director	98.1%	Passed
Election of Dr. Richard M. Steeves	Director	97%	Passed
Election of Cynthia L. Feldmann	Director	96.5%	Passed
Election of Richard C. Breeden	Director	96.4%	Passed
Election of Dr. Mohsen M. Sohi	Director	95.9%	Passed
Election of Dr. Jacqueline B. Kosecoff	Director	94.3%	Passed

2019

Item	Kind	Support	Outcome
The results of a proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 12, 2019, were as follows	Say on pay	98.4%	Passed
The results of a proposal to authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law were as follows	Auditor	98.3%	Passed
The results of a proposal to appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting were as follows	Auditor	96%	Passed
The results of a proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2020 were as follows	Auditor	96%	Passed
Election of Dr. Nirav R. Shah	Director	99.9%	Passed
Election of Walter M Rosebrough, Jr.	Director	99.6%	Passed
Election of Dr. Richard M. Steeves	Director	98.5%	Passed
Election of David B. Lewis	Director	98%	Passed
Election of Dr. Mohsen M. Sohi	Director	97.9%	Passed
Election of Richard C. Breeden	Director	97.6%	Passed
Election of Cynthia L. Feldmann	Director	97.4%	Passed
Election of Dr. Jacqueline B. Kosecoff	Director	96.9%	Passed

Proxy statements and vote results

Straight from Steris’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.

Year	Filing	Filed
2026	Vote results	2026-08-06
2026	Proxy statement	2026-06-11
2025	Vote results	2025-08-06
2025	Proxy statement	2025-06-12
2024	Vote results	2024-08-01
2024	Proxy statement	2024-06-12
2023	Vote results	2023-07-27
2023	Proxy statement	2023-06-07
2022	Vote results	2022-07-29
2022	Proxy statement	2022-06-07
2021	Vote results	2021-08-02
2021	Proxy statement	2021-06-07
2020	Vote results	2020-08-03
2020	Proxy statement	2020-06-05
2019	Vote results	2019-07-31
2019	Proxy statement	2019-06-05

Do you represent Steris? Claim this profile to respond to the campaigns listed here.

← All companies